Forum: Inflammatory Breast Cancer
12-06-2011, 09:36 PM
|
|
Replies: 0
Views: 7,283
two new IBC articles
ABSTRACT: Polycomb group protein EZH2 is frequently expressed in inflammatory breast cancer and is predictive of worse clinical outcome
[Cancer]
Background: Enhancer of zeste homolog 2 (EZH2), a...
|
